Gili Kenet Selected Research

Asparaginase (Elspar)

6/2010	Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study.
3/2009	Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gili Kenet Research Topics

Disease

67	Hemorrhage 04/2024 - 12/2002
56	Hemophilia A (Haemophilia) 04/2024 - 01/2006
22	Thrombosis (Thrombus) 01/2023 - 07/2008
18	Thrombophilia 03/2024 - 10/2004
16	Venous Thromboembolism 03/2024 - 09/2012
8	Hemophilia B (Haemophilia B) 05/2023 - 09/2016
7	Neoplasms (Cancer) 10/2023 - 01/2006
6	Thrombocytopenia (Thrombopenia) 11/2022 - 03/2011
6	Thromboembolism 11/2022 - 12/2009
4	Protein C Deficiency 03/2024 - 01/2009
4	Protein S Deficiency (Deficiency, Protein S) 03/2024 - 04/2010
4	Wounds and Injuries (Trauma) 01/2022 - 12/2002
4	Stroke (Strokes) 01/2013 - 01/2005
3	von Willebrand Diseases (von Willebrand's Disease) 11/2023 - 01/2021
3	Choroidal Neovascularization 06/2023 - 01/2019
3	Inflammation (Inflammations) 11/2022 - 05/2012
3	Venous Thrombosis (Deep-Vein Thrombosis) 10/2020 - 10/2011
3	Thrombasthenia (Glanzmann Thrombasthenia) 01/2019 - 09/2018
3	Ischemic Stroke 12/2009 - 01/2007
2	Thrombotic Microangiopathies 12/2023 - 11/2022
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 10/2019
2	Factor VII Deficiency (Hypoproconvertinemia) 12/2023 - 07/2003
2	Hypertension (High Blood Pressure) 05/2023 - 01/2014
2	Hypersensitivity (Allergy) 01/2023 - 12/2018
2	Pulmonary Embolism 01/2022 - 11/2016
2	Metrorrhagia (Spotting) 09/2021 - 01/2020
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 12/2017
2	Hemarthrosis 01/2021 - 01/2017
2	Neonatal Alloimmune Thrombocytopenia 12/2018 - 08/2017
2	Infections 03/2015 - 07/2008
2	Sepsis (Septicemia) 01/2015 - 12/2002
2	Necrosis 01/2015 - 02/2009
2	Disseminated Intravascular Coagulation 01/2015 - 07/2008
1	Injection Site Reaction 12/2023
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 11/2023
1	Epistaxis (Nosebleed) 11/2023
1	Disease Susceptibility (Diathesis) 11/2023
1	Cholelithiasis 05/2023

Drug/Important Bio-Agent (IBA)

23	Factor VIII (Coagulation Factor VIII)IBA 04/2024 - 01/2013
18	Hemostatics (Antihemorrhagics)IBA 11/2023 - 12/2002
16	emicizumabIBA 04/2024 - 11/2019
13	AntithrombinsIBA 03/2024 - 01/2009
13	AnticoagulantsIBA 03/2024 - 09/2012
13	Thrombin FDA Link 11/2023 - 07/2008
12	Protein CIBA 01/2021 - 01/2009
11	Prothrombin (Factor II)IBA 03/2024 - 01/2005
10	Blood Coagulation Factors (Coagulation Factor)IBA 03/2024 - 07/2008
10	Factor VIIa (Activated Factor VII)IBA 01/2024 - 12/2002
9	recombinant FVIIa (rFVIIa)FDA Link 01/2020 - 12/2002
8	AntibodiesIBA 12/2023 - 04/2011
8	RivaroxabanIBA 11/2022 - 12/2016
7	factor V LeidenIBA 03/2024 - 01/2005
7	Protein SIBA 01/2018 - 01/2009
6	Factor IX (Coagulation Factor IX)FDA LinkGeneric 04/2020 - 09/2016
5	Vitamin K FDA Link 01/2022 - 07/2008
5	Antiphospholipid AntibodiesIBA 10/2017 - 01/2009
4	Blood Group Antigens (Blood Groups)IBA 12/2023 - 02/2021
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2022 - 06/2010
4	Heparin (Liquaemin)FDA LinkGeneric 11/2022 - 06/2017
3	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2024 - 01/2020
3	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024 - 10/2007
3	BAY 94-9027IBA 01/2024 - 05/2020
3	human F8 protein FDA Link 01/2023 - 01/2020
3	Fibrinogen (Factor I)FDA Link 01/2022 - 05/2011
3	AlbuminsIBA 04/2020 - 09/2016
3	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2006
2	Valoctocogene RoxaparvovecIBA 04/2024 - 01/2023
2	Small Interfering RNA (siRNA)IBA 03/2024 - 05/2023
2	fitusiranIBA 03/2024 - 05/2023
2	TESIBA 12/2023 - 11/2022
2	recombinant factor VIII N8IBA 11/2023 - 01/2023
2	InflammasomesIBA 06/2023 - 11/2022
2	3K3A-APC proteinIBA 06/2023 - 11/2022
2	Retinaldehyde (Retinal)IBA 11/2022 - 01/2019
2	Inosine Triphosphate (ITP)IBA 01/2021 - 12/2017
2	Recombinant Fusion ProteinsIBA 04/2020 - 09/2016
2	von Willebrand FactorIBA 09/2019 - 01/2013
2	Surface-Active Agents (Surfactants)IBA 01/2018 - 11/2013
2	Factor V (Coagulation Factor V)IBA 01/2018 - 04/2014
2	anti-inhibitor coagulant complexIBA 01/2018 - 01/2017
2	ChitosanIBA 05/2017 - 03/2014
2	vinyltriethoxysilane (VTES)IBA 11/2016 - 01/2006
2	SteroidsIBA 05/2012 - 06/2010
2	ORALIT (ORS)IBA 10/2011 - 04/2010
2	Asparaginase (Elspar)FDA Link 06/2010 - 03/2009
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2009 - 01/2005
1	Chromogenic CompoundsIBA 04/2024
1	factor VII clotting antigenIBA 12/2023
1	Factor VII (Proconvertin)IBA 12/2023
1	Estrogens (Estrogen)FDA Link 10/2023

Therapy/Procedure

39	Therapeutics 04/2024 - 10/2003
6	Catheters 04/2021 - 03/2015
4	Operative Surgical Procedures 11/2023 - 09/2018
4	Central Venous Catheters 10/2020 - 03/2015
3	Minor Surgical Procedures (Minor Surgery) 11/2019 - 01/2017
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2019 - 01/2018
2	Duration of Therapy 05/2023 - 03/2019
2	Drug Therapy (Chemotherapy) 01/2022 - 03/2015
2	Injections 04/2020 - 09/2016
1	Ligation 12/2023